Cidara Therapeutics (NASDAQ:CDTX – Get Rating) and Cullinan Oncology (NASDAQ:CGEM – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current ratings […]
Cullinan Oncology (NASDAQ:CGEM) is a cancer focused drug developer with a mid stage pipeline. Their approach is to develop differentiated molecules with…
HC Wainwright reaffirmed their buy rating on shares of Cullinan Oncology (NASDAQ:CGEM – Get Rating) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $50.00 price objective on the stock. Separately, Morgan Stanley dropped their price objective on Cullinan Oncology from $27.00 to $19.00 and set an overweight […]